The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised ...
Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...
Here are three things to know. 1. Trogarzo is an antiretroviral medication for adult patients with HIV who do not respond to other HIV therapies on the market. 2. Clinicians administer the intravenous ...
Purpose: The pharmacology, efficacy, and safety of etravirine and its clinical utility with respect to the available alternative human immunodeficiency virus (HIV) treatment options are reviewed.
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial evaluated the treatment ...
News-Medical.Net on MSN
Immune dysfunction persists after combined TB and HIV therapy
The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – ...
GlobalData on MSN
JPM26: HIV pipeline dosing optionality gives Gilead advantage
Speaking at the J.P. Morgan Healthcare Conference 2026, CEO Daniel O’Day said that the company has seven pipeline drugs for ...
The announcement of the cuts prompted warnings from around the world about the potential consequences. In the Journal of ...
The Center for Women's Reproductive Care at Columbia University (CWRC; NY, USA) has been at the forefront of innovative therapy for HIV-serodiscordant couples in the USA. Appreciative of the CDC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results